Moneycontrol
HomeNewsIndiaEPFO puts in place mechanism to credit govt's contribution towards EPF, EPS under PM Garib Kalyan Yojana
Trending Topics

EPFO puts in place mechanism to credit govt's contribution towards EPF, EPS under PM Garib Kalyan Yojana

Accordingly, the relief announced by the government can be claimed by eligible organisations/establishments by filing electronic challan-cum-return (ECR).

April 11, 2020 / 17:26 IST
Story continues below Advertisement

Retirement fund body EPFO has put in place a mechanism to credit employers' and employees' contribution towards its social security schemes by the government under the PM Garib Kalyan Yojana amid the lockdown to contain COVID-19. The move would benefit around 79 lakh subscribers and 3.8 lakh firms with a total outgo of Rs 4,800 crore from the government.

"Employees Provident Fund Organisation (EPFO), has put in place an electronic mechanism for crediting EPF and EPS accounts of its subscribers as per the package announced by the Union Government under PM Gareeb Kakyan Yojna on March 26, 2020 for helping the poor to fight Corona pandemic," a labour ministry statement said.

Story continues below Advertisement

Accordingly, the relief announced by the government can be claimed by eligible organisations/establishments by filing electronic challan-cum-return (ECR).

The due amount on behalf of employers and employees reflected in the ECR on account of EPF and EPS (24 percent wages) will be credited by the central government for three months in UANs (universal account number) of contributory EPF members, earning monthly wage of less than Rs 15,000, who are already employed in EPF covered establishments/factories, employing up to one hundred employees with 90 percent or more of such employees earning monthly wage of less than Rs 15,000.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show